| Meghan Marie Mccabe, MA, CCC-SLP, TSSLD | |
|
300 Garden City Plz Ste 350, Garden City, NY 11530-3358 | |
| (516) 747-9030 | |
| Not Available |
| Full Name | Meghan Marie Mccabe |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 300 Garden City Plz Ste 350, Garden City, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154943504 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (* (Not Available)) | Secondary |
| 235Z00000X | Speech-language Pathologist | 031181 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Meghan Marie Mccabe, MA, CCC-SLP, TSSLD 388 Burkhard Ave, Mineola, NY 11501-1412 Ph: (516) 592-8186 | Meghan Marie Mccabe, MA, CCC-SLP, TSSLD 300 Garden City Plz Ste 350, Garden City, NY 11530-3358 Ph: (516) 747-9030 |
News Archive
A major new study by researchers at Harvard and McGill Universities - the largest ever to look at working conditions worldwide - finds the United States far behind other economically successful nations in terms of adopting policies that support workers and families.
By borrowing a tool from bacteria that infect plants, scientists have developed a new approach to eliminate mutated DNA inside mitochondria-the energy factories within cells. Doctors might someday use the approach to treat a variety of mitochondrial diseases, including the degenerative eye disease Leber hereditary optic neuropathy. The research, published online today in Nature Medicine, was funded by the National Eye Institute, a part of the National Institutes of Health.
NOXXON Pharma AG, the biopharmaceutical company focusing on the development of novel drugs based on its unique proprietary Spiegelmer® technology, today announced successful completion of the first phase I trial with its anti-inflammatory Spiegelmer® NOX-E36. This drug candidate will be developed for the treatment of complications of type 2 diabetes, preferentially diabetic nephropathy, but also others.
In an analysis that included data from 9 studies, having higher measures of walking speed among older adults was associated with increased length of survival, according to a study in the January 5 issue of JAMA.
› Verified 2 days ago
Madeline Smith, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 120 Whitehall Blvd, Garden City, NY 11530 Phone: 516-712-7036 | |
Marisa Lant, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 300 Garden City Plz, Garden City, NY 11530 Phone: 516-747-9030 | |
Maureen Dorothy Bock Murphy, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 300 Garden City Plz, Suite 350, Garden City, NY 11530 Phone: 516-747-9030 | |
Tracy Needham, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 585 Stewart Ave, Garden City, NY 11530 Phone: 516-627-3036 | |
North Shore Center For Speech, Language & Swallowing Disorders Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 585 Stewart Ave, Suite 310, Garden City, NY 11530 Phone: 516-627-3036 Fax: 516-627-6741 | |
Alexis Thomas, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 300 Garden City Plz Ste 350, Garden City, NY 11530 Phone: 516-747-9030 | |
Lori Hand, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 58 Roosevelt St, Garden City, NY 11530 Phone: 516-437-5402 |